Clinical Trials Logo

Clinical Trial Summary

This study is to evaluate the effectiveness of regenerative endodontics therapy in single-rooted permanent teeth with pulp necrosis,and compare the clinical efficacy of platelet rich fibrin (PRF) and blood clot (BC) as scaffolds.


Clinical Trial Description

Regenerative endodontics therapy (RET), based on the principles of tissue engineering, manipulates stem cells, scaffold, and bioactive growth factors to achieve the functional reconstruction of pulp tissue. RET has been recommended strongly as an alternative in treating immature permanent teeth with necrotic pulp in recent years, while root canal therapy (RCT) has been extensively applied in the treatment of mature permanent teeth with necrotic pulp. RCT contains the chemomechanical preparation of the infected root canals to eliminate the microorganisms, and root canal obturation with filling materials to reduce and prevent microbial contamination in root canal system. However, the root canal filling materials, such as Gutta-percha, are inert materials which fail to recover the physiological function of the pulp. As RET has been proved curative for immature permanent teeth diagnosed with pulp necrosis, doctors and researchers try to extend its application in the mature ones. Encouragingly, several RET cases for mature teeth reported in the literature have shown positive clinical outcomes. However, it still lacks long-term and well-designed randomized clinical trial with large sample size and following standardized protocol, hence this study is conducted to make up for it to achieve high-level evidence.

In the process of RET, the scaffold can provide nutrition and space, which are essential for the proliferation and differentiation of stem cells. Therefore, it is a crucial step to select a high-quality material as the scaffold. In many studies of RET procedures, blood clot (BC), generated by provoking apical bleeding into the root canal, is regarded as a scaffold. Nevertheless, it remains a common problem that operators may fail to induce apical bleeding or achieve adequate blood volume. Recent studies suggest that patelet rich fibrin (PRF), the second-generation platelet concentrate, can provide a fibrin network full of cytokines and growth factors, which may improve the desired biological outcome. Accordingly, we assumed that PRF could improve the curative effect for mature teeth in RET. The purpose of this study is to compare the clinical efficacy of PRF and BC as scaffolds in RET for the mature permanent tooth with pulp necrosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04313010
Study type Interventional
Source Southern Medical University, China
Contact Wanghong Zhao, Doctor
Phone 0086-020-62787680
Email zhaowh@smu.edu.cn
Status Recruiting
Phase N/A
Start date March 16, 2020
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT01976065 - Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots Phase 1
Active, not recruiting NCT03763110 - Photo-Activated Disinfection Versus Triple-Antibiotic Paste for Management of Necrotic Young Permanent Anterior Teeth N/A
Completed NCT00881907 - Tissue Characterization in Teeth Treated With a Regeneration Protocol Phase 0
Not yet recruiting NCT03813433 - Discoloration of Endosequence and Mineral Trioxde Aggregate in Revascularization of Necrotic Immature Permanent Teeth N/A
Completed NCT03589560 - Evaluation of Biodentine and Mineral Trioxide Aggregate in Revascularization of Non Vital Immature Anterior Teeth N/A
Not yet recruiting NCT03717337 - Success Rate of Single Versus Two Visit Regenerative Treatment Protocol in Non Vital Mature Anterior Teeth N/A
Completed NCT01817413 - Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma Phase 4
Completed NCT03849222 - Evaluation the Effect of Using of Apical Matrix With Apexification Procedure on Apical Healing of Necrotic Immature Teeth Phase 2/Phase 3
Completed NCT00881491 - Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste Phase 0